About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Dexketoprofen
- Procedure number
- PSUSA/00000997/202110
- Regulatory outcome
- Variation
Documents
Dexketoprofen : Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s) - PSUSA/00000997/202110
English (EN) (63.45 KB - PDF)
български (BG) (99.18 KB - PDF)
español (ES) (64.24 KB - PDF)
čeština (CS) (143.37 KB - PDF)
dansk (DA) (63.01 KB - PDF)
Deutsch (DE) (67.48 KB - PDF)
eesti keel (ET) (61.88 KB - PDF)
ελληνικά (EL) (101.45 KB - PDF)
français (FR) (91.76 KB - PDF)
hrvatski (HR) (158.53 KB - PDF)
italiano (IT) (81.34 KB - PDF)
latviešu valoda (LV) (160.12 KB - PDF)
lietuvių kalba (LT) (163.53 KB - PDF)
magyar (HU) (114.87 KB - PDF)
Malti (MT) (120.91 KB - PDF)
Nederlands (NL) (64.66 KB - PDF)
polski (PL) (122.32 KB - PDF)
português (PT) (81.31 KB - PDF)
română (RO) (118.16 KB - PDF)
slovenčina (SK) (145.32 KB - PDF)
slovenščina (SL) (143.41 KB - PDF)
Suomi (FI) (61.38 KB - PDF)
svenska (SV) (64.55 KB - PDF)